New Zealand - English - Medsafe (Medicines Safety Authority)

rex medical ltd - lamivudine 150mg; zidovudine 300mg;   - film coated tablet - 150mg/300mg - active: lamivudine 150mg zidovudine 300mg   excipient: colloidal silicon dioxide hypromellose magnesium stearate microcrystalline cellulose propylene glycol purified talc sodium starch glycolate titanium dioxide - zidovudine 300mg/lamivudine 150mg is indicated for the treatment of hiv infected adults and adolescents over the age of 12 years, with progressive immunodeficiency (cd4 = count = <500 cells/mm3).

Kenya - English - Pharmacy and Poisons Board

anhui biochem bio-pharmaceutical co., ltd no. 30 hongfeng road, hi-tech development zone, - zidovudine 300mg and lamivudine 150mg tablets - film-coated tablet - zidovudine 300mg and lamivudine 150mg tablets - antivirals for systemic use: combinations of

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - lamivudine, quantity: 150 mg; zidovudine, quantity: 300 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; microcrystalline cellulose; propylene glycol; magnesium stearate; sodium starch glycollate type a; titanium dioxide; hypromellose - lamivudine and zidovudine combination tablet is indicated for use alone or in combination with other antiretroviral therapies in the treatment of hiv infection.

Kenya - English - Pharmacy and Poisons Board

aurobindo pharma limited p.o.box 1541-00606 nairobi - lamivudine zidovudine efavirenz - tablet - lamivudine 150 mg zidovudine 300 mg efavirenz… - antivirals for systemic use:

Australia - English - Department of Health (Therapeutic Goods Administration)

viiv healthcare pty ltd - lamivudine, quantity: 150 mg; zidovudine, quantity: 300 mg - tablet, film coated - excipient ingredients: sodium starch glycollate; magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; titanium dioxide; hypromellose; polysorbate 80; macrogol 4000 - combivir is indicated for use alone or in combination with other antiretroviral therapies in the treatment of hiv infection.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

milpharm ltd - lamivudine; zidovudine - tablet - 150mg ; 300mg

Malta - English - Medicines Authority

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - zidovudine, lamivudine - film-coated tablet - zidovudine 300 mg lamivudine 150 mg - antivirals for systemic use

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - lamivudine 150mg; zidovudine 300mg - film coated tablet - active: lamivudine 150mg zidovudine 300mg excipient: colloidal silicon dioxide magnesium stearate microcrystalline cellulose opadry white propylene glycol purified water sodium starch glycolate - indicated for the treatment of hiv infected adults and adolescents over the age of 12 years, with progressive immunodeficiency (cd4+ count = < 500 cells/mm³).

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - lamivudine,zidovudine -

Kenya - English - Pharmacy and Poisons Board

macleods pharmaceuticals limited atlanta arcade church road near leela hotel - lamivudine 150 mg & zidovudine 300 mg tablets usp - film-coated tablet - each film coated tablet contains: lamivudine usp… - antivirals for systemic use: combinations of